Associations of Serum Isoflavone, Adiponectin and Insulin Levels with Risk for Epithelial Ovarian Cancer: Results of a Case-control Study |
Otokozawa, Seiko
(Department of Public Health, Sapporo Medical University School of Health Sciences)
Tanaka, Ryoichi (Department of Obstetrics and Gynecology, Sapporo Medical University School of Health Sciences) Akasaka, Hiroshi (Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Health Sciences) Ito, Eiki (Department of Obstetrics and Gynecology, Sapporo Medical University School of Health Sciences) Asakura, Sumiyo (Department of Public Health, Sapporo Medical University School of Health Sciences) Ohnishi, Hirofumi (Department of Public Health, Sapporo Medical University School of Health Sciences) Saito, Shigeyuki (Department of Nursing, Sapporo Medical University School of Health Sciences) Miura, Tetsuji (Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Health Sciences) Saito, Tsuyoshi (Department of Obstetrics and Gynecology, Sapporo Medical University School of Health Sciences) Mori, Mitsuru (Department of Public Health, Sapporo Medical University School of Health Sciences) |
1 | Ayyildiz T, Dolar E, Ugras N, et al, (2014). Association of adiponectin receptor (Adipo-R1/R2) expression and colorectal cancer. Asian Pacific J Cancer Prev, 15, 9385-90. DOI |
2 | Brokaw J, Katsaros D, Wiley A, et al (2007). IGF-1 in epithelial ovarian cancer and its role in disease progression. Growth Factors, 25, 346-54. DOI |
3 | Chang ET, Lee VS, Canchola AJ, et al (2007). Diet and risk of ovarian cancer in the california teachers study cohort. Am J Epidemiol, 165, 802-13. DOI |
4 | Collaborative Group on Epidemiological Studies of Ovarian cancer, Bera V, Doll R, et al (2008). Ovarian cancer and oral contraceptives; collaborative reanalysis of data from 45epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet, 371, 303-14. DOI |
5 | Coppola D, Saunders B, Fu L, et al (2007). The insulin -like growth factor 1 receptor transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas -receptor expression. Cancer Res, 59, 3264-70. |
6 | Dupont J, Reverchon M, Cloix L, et al (2012). Involvement of adipokines, AMPK, PI3K and the PPAR signaling pathways in ovarian follicle development and cancer. Int J Dev Biol, 56, 959-67. DOI |
7 | Fantuzzi G (2005). Adipose tissue, adipokines, and inflammations. J Allergy Clin Immunol, 115, 911-9. DOI |
8 | Giovannucci E (1995). Insulin and colon cancer. Cancer Causes Control, 6, 164-79. DOI |
9 | Gossner G, Choi M, Tan L, et al (2007). Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol, 105, 23-30. DOI |
10 | Gulcelik MA, Colakoglu K, Dincer H, et al (2012). Association between adiponectin and two different cancers; breast and colon. Asian Pac J Cancer Prev, 13, 395-8. DOI ScienceOn |
11 | Horn-Ross PL, John EM, Canchola AJ, et al (2003). Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst, 95, 1158-64. DOI |
12 | Lihn AS, Pedersen SB, Richelsen B (2005). Adiponectin; action, regulation and association to insulin sensitivity. Obes Rev, 6, 13-21. DOI |
13 | Kaaks R, Toniolo P, Akhmedkhanov A, et al (2000). Serum C-peptide, insulin -like growth factor (IGF)-1, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst, 92, 1592-600. DOI |
14 | Lee AH, Su D, Pasalich M, et al (2014). Soy and isoflavone intake associated with reduced risk of ovarian cancer in southern Chinese women. Nutr Res, 34, 302-7. DOI |
15 | Lee MM, Gomez SL, Chang JS, et al (2003). Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev, 12, 665-8. |
16 | Luhn P, Fallal CM, Weiss JM, et al (2013). Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev, 22, 1304-12. DOI |
17 | Lukanova A, Lundin, Toniolo P, et al (2002). Circulating levels of insulin-like growth -1 and risk of ovarian cancer. Int J Cancer, 101, 549-54. DOI |
18 | Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. DOI |
19 | Piver MS, Goldberg JM, Tsukada Y, et al (1996). Characteristics of familial ovarian cancer; a report of the first 1,000 Families in the Gilda Rander Familial ovarian cancer registry. Eur J Gynaecol Oncol, 17, 169-76. |
20 | Qu X-L, Fang Y, Zhang M, Zhang Y-Z (2014). Phytoestrogen intake and risk of ovarian cancer; a meta-analysis of 10 observational studies. Asian Pac J Cancer Prev, 15, 9085-91. DOI |
21 | Rossi M, Negri E, Lagiou P, et al (2008). Flavonoids and ovarian cancer risk; A case-control study in Italy. Int J Cancer, 123, 895-8. DOI |
22 | Risch A, Marrett LD, Jain M, et al (1996).Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol, 144, 363-72. DOI |
23 | Rizzuto I, Behrens RF, Smith LA (2013). Risk of ovarian cancer in women treated ovarian stimulating drugs for infertility. Cochrane Database Syst Rev, 8. |
24 | Roberts DL, Dive C, Renehan AG (2010). Biological mechanisms liking obesity and cancer risk; new perspectives. Annu Rev Med, 61, 301-16. DOI ScienceOn |
25 | Rufer CE, Glatt H, Kulling SK (2006). Structural elucidation of hydroxylated metabolites of the isoflavone equol by gas chromatogtaphy-mass spectrometry and high-performance liquid chromatography -mass spectrometry. Drug Metab Dispos, 34, 51-60. |
26 | Schoen RE, Tangen CM, Kuller LH, et al (1999). Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst, 91, 1147-54. DOI |
27 | Soslow RA (2008). Histologic subtypes of ovarian carcinoma; an overview. Int J Gynecol Patho, 127, 161-74. |
28 | Troisi R, Potischman N, Hoover RN, et al (1997). Insulin and endometrial cancer. Am J Epidemiol, 146, 476-82. DOI |
29 | Valladares M, Corsini G, Romero C (2014). Association between obesity and ovarian cancer. Rev Med Chil, 142, 593-8. DOI |
30 | Wang XL, Hur HG, Lee JH, et al (2005). Enantioselective synthesis of S equol from dihydro- daidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microbiol, 71, 214-9. DOI |
31 | Zhang M, Xie X, Lee AH, et al (2004). Soy and isoflavone intake are associated with reduced risk of ovarian cancer in Southeast China. Nutr Cancer, 49, 125-30. DOI |
32 | Yamamoto S, Sobue T, Kobayashi M, et al (2003). Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst, 95, 906-13. DOI |
![]() |